D-0150-2018 Class I Terminated

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
January 10, 2018
Initiation Date
October 20, 2017
Termination Date
June 2, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
183437 bottles

Product Description

diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977

Reason for Recall

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Distribution Pattern

Nationwide in the USA

Code Information

Lots: a) R83962, R93347, R93348, R93349, R93350, R93351, R93352, Exp. 2021 OCT 31; S57831, S57832, S57834, Exp. 2021 NOV 30 b) R93356, R93357, R93358, R97310, Exp. 2021 OCT 31.